The role of m6A modification in the biological functions and diseases
Abstract N6-methyladenosine (m6A) is the most prevalent, abundant and conserved internal cotranscriptional modification in eukaryotic RNAs, especially within higher eukaryotic cells. m6A modification is modified by the m6A methyltransferases, or writers, such as METTL3/14/16, RBM15/15B, ZC3H3, VIRMA...
Main Authors: | Xiulin Jiang, Baiyang Liu, Zhi Nie, Lincan Duan, Qiuxia Xiong, Zhixian Jin, Cuiping Yang, Yongbin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-020-00450-x |
Similar Items
-
miR-133b targets NCAPH to promote β-catenin degradation and reduce cancer stem cell maintenance in non-small cell lung cancer
by: Qiuxia Xiong, et al.
Published: (2021-07-01) -
m6A modification in RNA: biogenesis, functions and roles in gliomas
by: Yuhao Zhang, et al.
Published: (2020-09-01) -
The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases
by: Beijian Zhang, et al.
Published: (2021-11-01) -
The epitranscriptome in gastric cancer: the role of m6A mRNA modifications
by: Luís Filipe Costa Póvoas
Published: (2021) -
Regulatory Role of N6-methyladenosine (m6A) Modification in Osteosarcoma
by: Yujie Zhang, et al.
Published: (2021-05-01)